Central Pharma Cell And Gene Therapy Ltd
12769240
Some Concerns
- Negative net worth (-10)
- Loss before tax (-10)
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
- 1 outstanding charge (-2)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 27/07/2020
DIRECTOR
BRITISH · ENGLAND · Age 65
Also on 5 other boards
Persons with Significant Control
Central Pharma Contract Holdings Limited
Central Pharma Caxton Road, Elm Farm Industrial Estate, Bedford, MK41 0HT
Reg: 08126719 · United Kingdom · Private Company Limited By Shares
Notified 27/07/2020
Charges1 outstanding
CYNERGY BUSINESS FINANCE LIMITED
CompanyRankvs 48651+ SIC 74909 peers16
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
statements concerning the company's ability to continue as a going concern. As of 31 December 2024 Central Pharma Cell and Gene Therapy Limited has received on going financial support from the group. At the time of signing the financial statements the directors consider tha
Key FinancialsYear ending 31/12/2024
Turnover
£513k
Annual revenue
Net Worth
-£2.2M
Balance sheet strength
Cash
£4k
Cash in the bank
Profit Before Tax
-£292k
Bottom line earnings
Net Current Assets
-£2.0M
Working capital
Current Assets
£126k
Current Liabilities
£2.2M
Fixed Assets
£24k
Debtors
£123k
Cost of Sales
£46k
Gross Profit
£467k
Admin Expenses
£758k
Operating Profit
-£291k
Profit After Tax
-£292k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 0.06 |
| 2023 | 0.12 |
Derived from filed accounts. Not audited figures.